Kenya launches Oxford Astrazeneca vaccine trial amid second wave of coronavirus

“As cases continue to rise across the country, Kenyan scientists in the beachside destination of KIlifi are hard at work on the country’s first COVID-19 vaccine trial. On Oct. 30, Kenya Medical Research Institute Wellcome Trust, which is leading the study, launched a phase one trial of the Oxford Astrazeneca vaccine candidate.”

via The World
More analysis from COVID-19 Africa Watch: